人类结肠炎相关结肠直肠癌的进展伴随着具有丰富的病原生物的异位生物
Amr H Masaadeh1, Mohamed Eletrebi1, Bishal Parajuli1
1Department of Pathology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Gut microbes
|March 17, 2025
概括
人类结肠炎相关癌症 (CAC) 的微生物组差异使其与炎症性肠病 (IBD) 和结肠直肠癌 (CRC) 区别开来. 像pks+大肠杆菌这样的病原生物在CAC中更频繁,这表明它们在疾病进展中的作用.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 在瘤学瘤学.
背景情况:
- 在动物模型中,dysbiosis和pathobionts与大肠炎相关的癌症 (CAC) 有关.
- 它们在人类CAC中的作用在很大程度上是未知的.
- 了解这些微生物的作用对于疾病管理至关重要.
研究的目的:
- 与炎症性肠病 (IBD) 和偶发性结直肠癌 (CRC) 相比,确定人类CAC中的微生物群差异.
- 调查特定的病原生物与CAC.的关联.
- 探索肠道微生物群多样性与CCC中的临床结果之间的关系.
主要方法:
- 患者样本上的组织病理学和16S rDNA转基因组学.
- 病原生物特有的定量PCR (qPCR).
- 在CAC,CRC和IBD队列中比较微生物组组成.
主要成果:
- 在CAC,IBD和CRC诊断之间观察到明显的β多样性.
- 特定的分类群如阿克尔曼西亚和巴克特罗伊德斯spp. 它们分别富含CRC和IBD.
- 肠道细菌和pks+大肠杆菌被CAC丰富,特别是在转移和边缘.
结论:
- 人类粘膜微生物组区别于CAC和长期存在的IBD.
- 病原生物被认为是CAC进展的潜在标志物.
- 研究结果表明,通过基因毒性和宿主信号传递,病原生物通过IBD患者的致癌作用.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
10.0K
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
2.6K
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
106
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
106
01:17Chronic Bowel Disorders: Introduction
375
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
375
01:30Inflammatory Bowel Disease II: Crohn's Disease
151
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
151